Humasis Financial Statements From 2010 to 2025

205470 Stock  KRW 1,612  18.00  1.10%   
Humasis financial statements provide useful quarterly and yearly information to potential Humasis Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Humasis financial statements helps investors assess Humasis' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Humasis' valuation are summarized below:
Humasis Co does not presently have any fundamental trends for analysis.
Check Humasis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Humasis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Humasis financial statements analysis is a perfect complement when working with Humasis Valuation or Volatility modules.
  
This module can also supplement various Humasis Technical models . Check out the analysis of Humasis Correlation against competitors.

Humasis Co Company Current Valuation Analysis

Humasis' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Humasis Current Valuation

    
  603.35 B  
Most of Humasis' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humasis Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Humasis Co has a Current Valuation of 603.35 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Health Care Equipment & Supplies industry. The current valuation for all Republic of Korea stocks is significantly lower than that of the firm.

Humasis Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Humasis's current stock value. Our valuation model uses many indicators to compare Humasis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Humasis competition to find correlations between indicators driving Humasis's intrinsic value. More Info.
Humasis Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The ratio of Return On Equity to Return On Asset for Humasis Co is about  289.59 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Humasis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Humasis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Humasis Financial Statements

Humasis stakeholders use historical fundamental indicators, such as Humasis' revenue or net income, to determine how well the company is positioned to perform in the future. Although Humasis investors may analyze each financial statement separately, they are all interrelated. For example, changes in Humasis' assets and liabilities are reflected in the revenues and expenses on Humasis' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Humasis Co. Please read more on our technical analysis and fundamental analysis pages.
Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. The company was founded in 2000 and is based in Anyang, South Korea. HUMASIS is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with Humasis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Humasis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humasis will appreciate offsetting losses from the drop in the long position's value.

Moving together with Humasis Stock

  0.75950130 Access BioPairCorr

Moving against Humasis Stock

  0.54222800 SIMMTECHPairCorr
  0.51217270 Daishin Balance 1PairCorr
  0.48064760 Tokai Carbon KoreaPairCorr
  0.46048470 Daedong SteelPairCorr
  0.45003920 Namyang DairyPairCorr
The ability to find closely correlated positions to Humasis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Humasis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Humasis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Humasis Co to buy it.
The correlation of Humasis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Humasis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Humasis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Humasis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Humasis Stock

Humasis financial ratios help investors to determine whether Humasis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humasis with respect to the benefits of owning Humasis security.